These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3354232)
1. Metabolism and disposition of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate (MOTP) in rats and dogs. Kobayashi T; Hohnoki H; Esumi Y; Ohtsuki T; Washino T; Tanayama S Xenobiotica; 1988 Jan; 18(1):49-59. PubMed ID: 3354232 [TBL] [Abstract][Full Text] [Related]
2. Disposition in rats and dogs of ciglitazone, a new antidiabetic agent. Torii H; Yoshida K; Tsukamoto T; Tanayama S Xenobiotica; 1984 Mar; 14(3):259-68. PubMed ID: 6711015 [TBL] [Abstract][Full Text] [Related]
3. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs. Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426 [TBL] [Abstract][Full Text] [Related]
4. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
5. Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs. Yoshida K; Mitani M; Naeshiro I; Torii H; Tanayama S Antimicrob Agents Chemother; 1986 Jun; 29(6):1017-24. PubMed ID: 3729358 [TBL] [Abstract][Full Text] [Related]
6. Disposition of idebenone (CV-2619), a new cerebral metabolism improving agent, in rats and dogs. Torii H; Yoshida K; Kobayashi T; Tsukamoto T; Tanayama S J Pharmacobiodyn; 1985 Jun; 8(6):457-67. PubMed ID: 4057041 [TBL] [Abstract][Full Text] [Related]
7. Disposition of ipriflavone (TC-80) in rats and dogs. Yoshida K; Tsukamoto T; Torii H; Doi T; Naeshiro I; Shibata K; Uemura I; Tanayama S Radioisotopes; 1985 Nov; 34(11):618-23. PubMed ID: 3834524 [TBL] [Abstract][Full Text] [Related]
8. Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs. Tagawa Y; Kiyota Y; Yoshimura Y; Motohashi M; Tanayama S Arzneimittelforschung; 1998 Jul; 48(7):750-7. PubMed ID: 9706376 [TBL] [Abstract][Full Text] [Related]
9. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review. Setnikar I; Rovati LC Arzneimittelforschung; 2001 Sep; 51(9):699-725. PubMed ID: 11642003 [TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of [14C]-haloperidol in rats. Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663 [TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate, a specific PAF antagonist, in endotoxin and anaphylactic shock. Terashita Z; Imura Y; Nishikawa K; Sumida S Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():715-7. PubMed ID: 3004156 [No Abstract] [Full Text] [Related]
12. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man. Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys. Sugimoto T; Hayashi T; Okita A; Morino A Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298 [TBL] [Abstract][Full Text] [Related]
14. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys. Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675 [TBL] [Abstract][Full Text] [Related]
15. The metabolic fate of Sormodren (bornaprine hydrochloride) in animals and humans. Mayo BC; Biggs SR; Chasseaud LF; Hawkins DR; Darragh A; O'Kelly DA Xenobiotica; 1980 Dec; 10(12):873-88. PubMed ID: 7210700 [TBL] [Abstract][Full Text] [Related]
16. Absorption, distribution and excretion of [14C]-Lesopitron after single and repeated administration in rats and dogs. Serafini MT; Puig S; García-Encina G; Farran R; García-Soret A; Moragon T; Martínez L Methods Find Exp Clin Pharmacol; 1997; 19(1):61-72. PubMed ID: 9098842 [TBL] [Abstract][Full Text] [Related]
17. Metabolic fate of SCE-1365, a new broad-spectrum cephalosporin, after parenteral administration to rats and dogs. Tanayama S; Yoshida K; Adachi K; Kondo T Antimicrob Agents Chemother; 1980 Oct; 18(4):511-8. PubMed ID: 6934706 [TBL] [Abstract][Full Text] [Related]
18. Disposition of [14C]velnacrine maleate in rats, dogs, and humans. Turcan RG; Hillbeck D; Hartley TE; Gilbert PJ; Coe RA; Troke JA; Vose CW Drug Metab Dispos; 1993; 21(6):1037-47. PubMed ID: 7905382 [TBL] [Abstract][Full Text] [Related]
19. Disposition of TAK-044, a new endothelin antagonist, in rats and dogs. Maeshiba Y; Takeuchi T; Kondo T; Yamashita K; Tsukuda R; Yoshimura Y Arzneimittelforschung; 2002; 52(8):587-92. PubMed ID: 12236045 [TBL] [Abstract][Full Text] [Related]
20. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide. Kurebayashi H; Betsui H; Ohno Y Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]